NO20025901L - Antipyretisk preparat inneholdende xylitol - Google Patents
Antipyretisk preparat inneholdende xylitolInfo
- Publication number
- NO20025901L NO20025901L NO20025901A NO20025901A NO20025901L NO 20025901 L NO20025901 L NO 20025901L NO 20025901 A NO20025901 A NO 20025901A NO 20025901 A NO20025901 A NO 20025901A NO 20025901 L NO20025901 L NO 20025901L
- Authority
- NO
- Norway
- Prior art keywords
- preparation containing
- antipyretic
- containing xylitol
- antipyretic preparation
- xylitol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Et antipyretisk preparat ment for administrering på en hvilken som helst måte forskjellig fra oral og omfattende xylitol. Mer spesielt beskrives det et antipyretisk preparat bestående av et antipyretikum og en synergistisk mengde xylitol. Videre beskrives anvendelsen av dette antipyretiske preparat i farmasøytiske anvendelser der xylitol kan benyttes som medisinsk produkt med antipyretisk effekt, for eksempel i kombinasjon med et annet medisinsk produkt fra familien antipyretiske analgetika som eventuelt kan ha anti-inflammatorisk virkning. Det beskrives videre produktets anvendelse for behandling av infeksjoner valgt fra gruppen parasittiske, virale eller bakterielle infeksjoner men også ved behandling av hjerteslag, forbrenninger, forgiftninger med et kjemisk produkt eller forstyrrelser i funksjonen som regulerer kroppstemperaturen.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0115917A FR2833173B1 (fr) | 2001-12-10 | 2001-12-10 | Preparation antipyretique renfermant du xylitol |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20025901D0 NO20025901D0 (no) | 2002-12-09 |
NO20025901L true NO20025901L (no) | 2003-06-11 |
Family
ID=8870281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025901A NO20025901L (no) | 2001-12-10 | 2002-12-09 | Antipyretisk preparat inneholdende xylitol |
Country Status (10)
Country | Link |
---|---|
US (2) | US20030109565A1 (no) |
EP (1) | EP1317922B1 (no) |
JP (1) | JP2003171266A (no) |
CN (1) | CN1432357A (no) |
AT (1) | ATE359770T1 (no) |
CA (1) | CA2413024A1 (no) |
DE (1) | DE60219578D1 (no) |
FR (1) | FR2833173B1 (no) |
MX (1) | MXPA02012232A (no) |
NO (1) | NO20025901L (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070048358A1 (en) * | 2005-08-31 | 2007-03-01 | Schorr Phillip A | Antimicrobial substrates |
US20070048344A1 (en) * | 2005-08-31 | 2007-03-01 | Ali Yahiaoui | Antimicrobial composition |
US20070048356A1 (en) * | 2005-08-31 | 2007-03-01 | Schorr Phillip A | Antimicrobial treatment of nonwoven materials for infection control |
JP2008266203A (ja) * | 2007-04-19 | 2008-11-06 | Bussan Food Science Kk | 活性酸素種消去酵素群の活性を向上させる方法 |
IL206739A (en) * | 2010-06-30 | 2016-06-30 | David Segal | An injectable drug containing silitol as an active substance |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2833M (no) * | 1962-06-12 | 1964-10-05 | I N I C O Ind Nuclear Invest C | |
GB1212115A (en) * | 1967-11-29 | 1970-11-11 | Far Eastern Detailers Ltd | Pharmaceutical composition comprising magnesium acetylsalicylate and method for preparing same |
DE4102629A1 (de) * | 1991-01-30 | 1992-08-06 | Bayer Ag | Pharmazeutischer kaugummi mit acetylsalicylsaeure |
US5331000A (en) * | 1992-03-09 | 1994-07-19 | Sepracor Inc. | Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen |
DE69727922T2 (de) * | 1996-04-16 | 2005-01-20 | Novartis Consumer Health S.A. | Schnell zerfallende orale dosierungsform |
US5719196A (en) * | 1996-07-24 | 1998-02-17 | Leiras Oy | Method of treating respiratory infections or complications derived therefrom in humans which includes oral administration of xylitol |
US6270790B1 (en) * | 1998-08-18 | 2001-08-07 | Mxneil-Ppc, Inc. | Soft, convex shaped chewable tablets having reduced friability |
US6447754B1 (en) * | 2000-01-24 | 2002-09-10 | Akpharma Inc. | Oral rinse methods and compositions |
-
2001
- 2001-12-10 FR FR0115917A patent/FR2833173B1/fr not_active Expired - Fee Related
-
2002
- 2002-12-02 DE DE60219578T patent/DE60219578D1/de not_active Expired - Lifetime
- 2002-12-02 AT AT02292961T patent/ATE359770T1/de not_active IP Right Cessation
- 2002-12-02 EP EP02292961A patent/EP1317922B1/fr not_active Expired - Lifetime
- 2002-12-06 CA CA002413024A patent/CA2413024A1/fr not_active Abandoned
- 2002-12-09 NO NO20025901A patent/NO20025901L/no not_active Application Discontinuation
- 2002-12-09 US US10/314,515 patent/US20030109565A1/en not_active Abandoned
- 2002-12-10 CN CN02154259A patent/CN1432357A/zh active Pending
- 2002-12-10 JP JP2002358676A patent/JP2003171266A/ja not_active Withdrawn
- 2002-12-10 MX MXPA02012232A patent/MXPA02012232A/es not_active Application Discontinuation
-
2006
- 2006-02-24 US US11/360,594 patent/US20060142254A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20025901D0 (no) | 2002-12-09 |
ATE359770T1 (de) | 2007-05-15 |
FR2833173A1 (fr) | 2003-06-13 |
MXPA02012232A (es) | 2005-06-06 |
US20060142254A1 (en) | 2006-06-29 |
CN1432357A (zh) | 2003-07-30 |
US20030109565A1 (en) | 2003-06-12 |
FR2833173B1 (fr) | 2004-08-27 |
DE60219578D1 (de) | 2007-05-31 |
JP2003171266A (ja) | 2003-06-17 |
CA2413024A1 (fr) | 2003-06-10 |
EP1317922B1 (fr) | 2007-04-18 |
EP1317922A1 (fr) | 2003-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1073470E (pt) | Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos | |
ITRM920361A1 (it) | Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. | |
NO20041270D0 (no) | Farmasoytiske sammensetninger som innbefatter kolloidal silikondioksid | |
PL410219A1 (pl) | Kompozycja zawierająca koniugat leku obejmujący pochodne kalicheamycyny i przeciwciało, oraz kompozycja farmaceutyczna ją zawierająca | |
NO20042739L (no) | Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan | |
YU23599A (sh) | Stabilizovani antihistaminski sirup | |
ATE303149T1 (de) | Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil | |
DK1300398T3 (da) | Propan-1,3-dionderivat | |
MXPA02009773A (es) | Derivados de indolin-2-ona y su uso como ligandos de receptores de ocitocina. | |
HK1155146A1 (zh) | 作為藥物活性劑的茚衍生物 | |
CA2347195A1 (en) | Oral pharmaceutical compositions containing buprenorphin | |
NO20013060D0 (no) | Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff | |
NO20034527L (no) | 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser | |
BR0212353A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
CY1112057T1 (el) | Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι | |
EP1607097A3 (en) | Stabilized compositions containing an oxygen-labile agent | |
NO20025901D0 (no) | Antipyretisk preparat inneholdende xylitol | |
CA2442210A1 (en) | Aryl oxime-piperazines useful as ccr5 antagonists | |
DE60001366D1 (de) | Orale zusammensetzung enthaltend perlit | |
DE50213012D1 (de) | Polyamide-zusammensetzungen enthaltend antioxidantien | |
NO20034529D0 (no) | 3,7-diazabicyklo(3,3,1) formuleringer samt antiarytmiforbindelser | |
EP0987266A4 (en) | BIPHENYL DERIVATIVES AND MEDICAL PREPARATIONS | |
NO20034528L (no) | 3,7-diazabicyklo(3,3,1) formuleringer som antiarytmiforbindelser | |
WO2001070184A3 (en) | A composition containing monoterpenes for topical oral administration | |
BR0213463A (pt) | Composições farmacêuticas contendo macrólidos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |